This section has no associated Explanatory Memorandum
105. In regulation 137 (amendment of regulation 171 (exempt advanced therapy medicinal products)), for “substitute “regulation 49(1)”.” substitute—U.K.
“substitute—
“(i)in the case of a product for sale or supply in Northern Ireland, Regulation (EC) No 726/2004, and
(ii)in the case of a product for sale or supply in Great Britain, regulation 49(1).”.”.
Commencement Information
I1Sch. 2 para. 105 in force at 31.12.2020 immediately before IP completion day, see reg. 1